LogicBio Therapeutics (LOGC) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Research and development: 124.3K
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: +42.9%
Financial Fact:
Research and development: 124.3K
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.07).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report
- GMR Solutions to reprice $2.9B term loan, pay down $200M in debt
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
